Cardiologia

Miocardite após 3ª dose de vacina da Pfizer em recrutas militares em Israel.

22 Mar, 2022 | 11:49h

Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel – JAMA

Conteúdos relacionados:

Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

---

M-A | Prevalência da doença microvascular coronariana e do vasoespasmo coronariano em pacientes com doença arterial coronariana não obstrutiva.

22 Mar, 2022 | 11:42h

Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis – Journal of the American Heart Association

---

Editorial | BNP nem sempre é útil na insuficiência cardíaca com fração de ejeção preservada.

22 Mar, 2022 | 11:32h

Editorial: BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction – European Heart Journal

Estudo original: Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality – European Heart Journal (link para o resumo – $ para o texto completo)

---

Hiper-reatividade da pressão arterial à posição em pé: um preditor de desfechos adversos em pacientes hipertensos jovens.

22 Mar, 2022 | 11:30h

Blood Pressure Hyperreactivity to Standing: a Predictor of Adverse Outcome in Young Hypertensive Patients – Hypertension (link para o resumo – $ para o texto completo)

Comunicado de imprensa: If blood pressure rises upon standing, so may risk for heart attack – American Heart Association

Comentários:

BP Hyperreactivity to Standing Tied to CV, Renal Events – HealthDay

Young hypertensives: increase in blood pressure on standing linked to increase in adverse events – MedicalResearch

---

Estudo randomizado | Suplementação de flavonóis de cacau mostrou-se promissora na prevenção de eventos cardiovasculares.

21 Mar, 2022 | 16:29h

Effect of cocoa flavanol supplementation for prevention of cardiovascular disease events: The COSMOS randomized clinical trial – American Journal of Clinical Nutrition

Comentário: New trial finds signs of preventive cardiovascular effects for cocoa flavanols – Brigham and Women’s Hospital

 

Comentário no Twitter (fio – clique para saber mais)

In @AJCNutrition: @HowardSesso, Dr. JoAnn Manson of @BWHDPM @BrighamWomens & colleagues report the main findings of the first ever randomized trial of a cocoa flavanol supplement on cardiovascular disease endpointshttps://t.co/0F5v8WqzdM and https://t.co/vA3wwT0Amw (1 of 5) pic.twitter.com/X08hiNUCzK

— BrighamResearch (@BrighamResearch) March 16, 2022

 

---

Posicionamento científico AHA | Avanços no manejo da transição de adolescentes com doença cardíaca congênita para a idade adulta.

21 Mar, 2022 | 16:23h

Advances in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: A Practical Approach to Transition Program Design: A Scientific Statement From the American Heart Association – Journal of the American Heart Association

Comunicado de imprensa: For youth with a heart defect, shift to adult-focused care is key to health, quality of life – American Heart Association

---

Atualização | Hipertensão no paciente internado.

21 Mar, 2022 | 16:21h

Hypertension in the hospitalized patient: An update – Nefrología

---

Estudo de coorte | Características e desfechos do infarto agudo do miocárdio tipo 2.

21 Mar, 2022 | 16:05h

Characteristics and Outcomes of Type 2 Myocardial Infarction – JAMA Cardiology (link para o resumo – $ para o texto completo)

Comentários:

Type 2 MI Not Uncommon in the Emergency Department – TCTMD

Type 2 Myocardial Infarction: Clinical Characteristics and Outcomes – American College of Cardiology

 

Comentário no Twitter

Among patients presenting with acute chest discomfort to the emergency department, tachyarrhythmias and hypertension are responsible for more than two thirds of type 2 myocardial infarction and result in a lower mortality compared to other triggers. https://t.co/ODMCmOjeQO

— JAMA Cardiology (@JAMACardio) March 10, 2022

 

---

Evidência atual e diretriz prática | Identificação e tratamento da hipertensão arterial usando a pressão arterial durante o exercício.

21 Mar, 2022 | 16:00h

The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance – International Journal of Environmental Research and Public Health

---

Decisão do consenso de especialistas da ACC de 2022 sobre sequelas cardiovasculares de COVID-19 em adultos: miocardite e outros envolvimentos miocárdicos, sequelas pós-agudas da infecção pelo SARS-CoV-2 e volta aos esportes.

17 Mar, 2022 | 13:25h

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Comentários:

ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology

ACC Releases Guidance on CV Issues With COVID-19 – TCTMD

Pontos principais: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19

Conteúdos relacionados:

Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.

The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.

COVID-19 infections increase risk of heart conditions up to a year later, study finds.

 

Comentário no Twitter (fio – clique para saber mais)

Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem

— American College of Cardiology (@ACCinTouch) March 16, 2022

 

---